腸疾患検査市場

出版：MarketsandMarkets

Enteric Disease Testing Market by Technology (Traditional and Rapid), End Use (Food (Meat, Poultry, Seafood, Dairy, Processed Foods, and Fruits & Vegetables) and Water), Pathogen Tested, and Region – Global Forecast to 2026

–

–

技術（従来型および迅速）、最終用途[食品（肉、鶏肉、シーフード、乳製品、加工食品、果物と野菜）、水]、病原体検査済み、地域 別

The global market for enteric disease testing is estimated at USD 1.8 billion in 2021; it is projected to grow at a CAGR of 6.0% to reach USD 2.4 billion by 2026. Foodborne illnesses have affected socioeconomic development by straining health care systems and trade. The factors fueling the growth of the enteric disease testing market are the implementation of stringent regulations related to contaminant detection, growth in consumer awareness, and humid atmospheric conditions, which are leading to an increase in contamination in food. In order to address enteric disease concerns, caused by foodborne illness, skey players in the various regions will need to further improve upon their food safety monitoring programs.

The food segment is estimated to hold the largest market share in the by end use segment for the enteric disease testing market.
The global food trade has been expanding and providing consumers with access to a wider variety of foods throughout the year. Expanding trade has led to the emergence of food contaminants, bringing diversity of food safety regulations and standards in different countries into focus. Growth in international trade creates the need for global mandates and regulations on food safety, which is a significant factor that drives the market for enteric disease testing.

By technology, the rapid technology segment is projected to account for the fastest market share in enteric disease testing market.

Rapid technology is widely used by various testing companies as it offers various advantages like quick results, greater sensitivity, and reliability, which have enabled manufacturers of assured claims to provide safety and quality in their products. Technological advancements, such as chromatography and spectrometry, witness low adoption in South America and Africa but witness increasing adoption in countries of the Asia Pacific region due to the growing investments from current market leaders.

The meat, poultry and seafood sub-segment within the food end use segment is estimated to hold the largest market share of enteric disease testing market over the forecast period.

Bacterial contamination takes place at all stages of slaughtering, leading to foodborne diseases. Defeathering or skinning is a stage where maximum contamination occurs due to improper handling of animals and unhygienic conditions. Inappropriate equipment cleaning procedures have been responsible for the cross-contamination of products. Thus, the demand for their testing is increasing in meat, poultry, and seafood products
The North American region is estimated to account for the largest market share in the global enteric disease testing market.

The North American region is considered to have one of the most advanced food safety programs, however, it faces major challenges. Several factors affect food safety, these include introduction & use of new technologies, more sophisticated distribution systems, inappropriate production and manufacturing systems, and increased access to imported foods. Outsourcing enteric diseases testing has benefited food producers in cutting down costs and has encouraged the growth of this market.

Break-up of Primaries
By Company Type: Tier 1: 65%, Tier 2: 20%, and Tier 3: 15%
By Designation: C-Level – 45%, Director Level – 30%, others- 25%
By Region: North America – 10%, Europe – 45%, Asia Pacific – 25%, South America – 5%, and Rest of the World (RoW) – 15%.

Leading players profiled in this report

•SGS SA (Switzerland)
•Eurofins Scientific (Luxembourg)
•Intertek Group plc (UK)
•Bureau Veritas (France)
•ALS Limited (Australia)
•TÜV SÜD (Germany)
•NEOGEN Corporation (US)
•Mérieux NutriSciences (US)
•AsureQuality (New Zealand)

Research Coverage
This report segments the enteric disease testing market on the basis of pathogen tested, technology, end use, and region. In terms of insights, this research report focuses on various levels of analyses—competitive landscape, end-use analysis, and company profiles—which together comprise and discuss the basic views on the emerging & high-growth segments of the Enteric disease testing market, the high-growth regions, countries, government initiatives, market disruption, drivers, restraints, opportunities, and challenges.
Reasons to buy this report
•To get a comprehensive overview of the enteric disease testing market
•To gain wide-ranging information about the top players in this industry, their product portfolios, and key strategies adopted by them.
•To gain insights about the major countries/regions, in which the enteric disease testing market is flourishing.

目次

1INTRODUCTION30
1.1OBJECTIVES OF THE STUDY30
1.2MARKET DEFINITION30
1.3STUDY SCOPE31
FIGURE 1ENTERIC DISEASE TESTING MARKET SEGMENTATION31
1.3.1REGIONAL SEGMENTATION31
1.4INCLUSIONS & EXCLUSIONS32
1.4.1PERIODIZATION CONSIDERED33
1.5CURRENCY CONSIDERED33
TABLE 1USD EXCHANGE RATES, 2015–201934
1.6STAKEHOLDERS34
2RESEARCH METHODOLOGY35
2.1RESEARCH DATA35
FIGURE 2ENTERIC DISEASE TESTING MARKET: RESEARCH DESIGN35
2.1.1SECONDARY DATA36
2.1.1.1Key data from secondary sources36
2.1.2PRIMARY DATA37
2.1.2.1Key industry insights37
2.1.2.2Breakdown of primary interviews38
FIGURE 3BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION38
2.2MARKET SIZE ESTIMATION39
2.2.1BOTTOM-UP APPROACH39
2.2.2TOP-DOWN APPROACH39
FIGURE 4MARKET SIZE ESTIMATION METHODOLOGY APPROACH40
2.3DATA TRIANGULATION41
FIGURE 5DATA TRIANGULATION METHODOLOGY41
2.3.1ENTERIC DISEASE TESTING MARKET SIZE ESTIMATION: SUPPLY SIDE42
FIGURE 6MARKET SIZE ESTIMATION OF ENTERIC DISEASE TESTING MARKET, 202042
2.3.2ENTERIC DISEASE TESTING MARKET SIZE ESTIMATION: DEMAND SIDE42
2.4RESEARCH ASSUMPTIONS43
2.5RESEARCH LIMITATIONS44
2.6MARKET SCENARIOS CONSIDERED FOR THE IMPACT OF COVID-1944
2.7SCENARIO-BASED MODELLING45
2.8COVID-19 HEALTH ASSESSMENT45
FIGURE 7COVID-19: GLOBAL PROPAGATION45
FIGURE 8COVID-19 PROPAGATION: SELECT COUNTRIES46
2.9COVID-19 ECONOMIC ASSESSMENT47
FIGURE 9REVISED GROSS DOMESTIC PRODUCT FORECASTS FOR SELECT G20 COUNTRIES IN 202047
2.9.1COVID-19 ECONOMIC IMPACT—SCENARIO ASSESSMENT48
FIGURE 10CRITERIA IMPACTING GLOBAL ECONOMY48
FIGURE 11SCENARIOS IN TERMS OF RECOVERY OF GLOBAL ECONOMY49
3EXECUTIVE SUMMARY51
4PREMIUM INSIGHTS54
4.1OPPORTUNITIES IN THE ENTERIC DISEASE TESTING MARKET54
4.2NORTH AMERICA: ENTERIC DISEASE TESTING MARKET, BY END USE & COUNTRY55
4.3ENTERIC DISEASE TESTING MARKET, BY PATHOGEN55
FIGURE 18SALMONELLA TO ACCOUNT FOR THE LARGEST SHARE FOR ENTERIC DISEASE TESTING IN 202055
4.4ENTERIC DISEASE TESTING MARKET, BY TECHNOLOGY56
4.5ENTERIC DISEASE TESTING MARKET IN FOOD, BY REGION & SUBSEGMENT56
4.6ENTERIC DISEASE TESTING MARKET: MAJOR REGIONAL SUBMARKETS57
5MARKET OVERVIEW58
5.1INTRODUCTION58
5.2MACROECONOMIC INDICATORS58
5.2.1INCREASE IN FOODBORNE ILLNESSES58
FIGURE 22NUMBER OF FOODBORNE ILLNESSES ACROSS THE GLOBE, 2020 (MILLION)59
FIGURE 23US: TOP FIVE PATHOGENS CONTRIBUTING TO FOODBORNE ILLNESSES, 202059
5.3MARKET DYNAMICS60
FIGURE 24ENTERIC DISEASE TESTING MARKET DYNAMICS60
5.3.1DRIVERS60
5.3.1.1Increase in the number of food recalls60
FIGURE 25EU: NUMBER OF FOOD RECALLS, 2017–202061
FIGURE 26US: REASONS FOR RECALL OF FOOD, 202061
5.3.1.2Rise in demand for convenience foods61
FIGURE 27READY-TO-EAT FOODS MOST AFFECTED BY FOOD RECALLS, 202062
FIGURE 28RISE IN GLOBAL MEAT EXPORTS, 2017–2020 (KT)62
5.3.1.3Increase in global trade owing to higher disposable income among consumers62
FIGURE 29GLOBAL AGRI-FOOD EXPORT VALUE, BY KEY COUNTRY,
2016–2018 (USD BILLION)63
FIGURE 30COUNTRY-WISE PREPARED FOODS TRADE SCENARIOS, BY KEY COUNTRY, 2019 (USD MILLION)63
5.3.2RESTRAINTS64
5.3.2.1Lack of proper regulations governing pathogen testing in the developing economies64
 
5.3.3OPPORTUNITIES64
5.3.3.1Technological innovations in the food safety testing industry64
5.3.3.2R&D investment directed toward the development of PCR technology for improved pathogen testing64
TABLE 2R&D INVESTMENT BY MAJOR COMPANIES65
5.3.4CHALLENGES65
5.3.4.1High cost associated with testing of food and water65
6INDUSTRY TRENDS66
6.1INTRODUCTION66
6.2REGULATORY FRAMEWORK66
6.2.1INTRODUCTION66
6.2.2INTERNATIONAL BODIES FOR FOOD SAFETY STANDARDS AND REGULATIONS66
6.2.2.1Codex Alimentarius Commission (CAC)66
6.2.2.2Global Food Safety Initiative (GFSI)66
6.2.3NORTH AMERICA67
6.2.3.1US regulations67
6.2.3.2Mexico68
6.2.3.3Canada68
6.2.4EUROPE69
6.2.4.1Microbiological criteria regulation70
6.2.4.2General food law for food safety70
6.2.4.3Germany70
6.2.4.4UK71
6.2.4.5France71
6.2.4.6Italy71
6.2.4.7Poland72
6.2.5ASIA PACIFIC72
6.2.5.1China72
TABLE 3PATHOGEN LIMITS FOR FOOD72
6.2.5.2India73
6.2.5.3Japan74
6.2.5.4Australia74
6.2.5.5New Zealand75
6.2.6SOUTH AMERICA75
6.2.6.1Brazil75
6.2.6.2Ministry of Agriculture, Livestock, and Food Supply (MAPA)75
6.2.6.3Ministry of Health (MS)75
6.2.6.4Argentina76
6.3PORTER’S FIVE FORCES ANALYSIS77
TABLE 4ENTERIC DISEASE TESTING MARKET: PORTER’S FIVE FORCES ANALYSIS77
6.3.1THREAT OF NEW ENTRANTS77
6.3.2THREAT OF SUBSTITUTES77
6.3.3BARGAINING POWER OF SUPPLIERS78
6.3.4BARGAINING POWER OF BUYERS78
6.3.5DEGREE OF COMPETITION78
6.4MARKET ECOSYSTEM79
FIGURE 31ENTERIC DISEASE TESTING MARKET ECOSYSTEM MAP79
6.4.1UPSTREAM79
6.4.2DOWNSTREAM79
TABLE 5COMPANY MARKET ECOSYSTEM80
6.5SUPPLY CHAIN ANALYSIS81
FIGURE 32REGULATORY BODIES: ENTERIC DISEASE TESTING MARKET81
6.5.1R&D82
6.5.2PRODUCTION82
6.5.3PROCESSING & TRANSFORMING82
6.5.4TRANSPORTATION82
6.5.5FINAL PREPARATION82
6.5.6DISTRIBUTION82
6.6TECHNOLOGY ANALYSIS83
6.7PATENT ANALYSIS84
FIGURE 33PATENT ANALYSIS, 2017-202084
TABLE 6KEY PATENTS FILED IN THE ENTERIC DISEASES TESTING MARKET,
2018- 202185
6.8CASE STUDIES85
TABLE 7AUTOMATED PATHOGEN DETECTION USING VIDAS ADVANCED TESTING SOLUTION85
6.9DISRUPTIONS IMPACTING BUYERS IN THE MARKET86
FIGURE 34THE DEMAND FOR CONVENIENCE FOODS IS DRIVING THE MARKET FOR ENTERIC DISEASE TESTING IN FROZEN FRUITS & VEGETABLES86
6.10IMPACT OF COVID-19 ON MARKET DYNAMICS86
6.10.1COVID-19 INCREASED THE DEMAND FOR FOOD SAFETY AND ASSESSMENT87
6.10.2COVID-19 HAS SHIFTED THE FOCUS TOWARDS GENERAL HYGIENE SERVICES FROM FOOD SAFETY87
7ENTERIC DISEASE TESTING MARKET, BY PATHOGEN88
7.1INTRODUCTION89
FIGURE 35ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN,
2021 VS. 2026 (USD MILLION)89
TABLE 8PATHOGENESIS OF COMMON PATHOGENS90
FIGURE 36US: FOODBORNE DISEASE OUTBREAKS, OUTBREAK-ASSOCIATED ILLNESSES, AND HOSPITALIZATIONS, 201990
TABLE 9US: INCIDENCE OF BACTERIAL AND PARASITIC INFECTIONS, 201991
TABLE 10ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN,
2016–2020 (USD MILLION)91
TABLE 11ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN,
2021–2026 (USD MILLION)92
7.1.1COVID-19 IMPACT ON THE ENTERIC DISEASE TESTING MARKET,
BY PATHOGEN92
7.1.1.1Realistic Scenario92
TABLE 12REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY PATHOGEN, 2016–2020 (USD MILLION)92
TABLE 13REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY PATHOGEN, 2021–2026 (USD MILLION)93
7.1.1.2Optimistic Scenario93
TABLE 14OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY PATHOGEN, 2016–2020 (USD MILLION)93
TABLE 15OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY PATHOGEN, 2021–2026 (USD MILLION)94
7.1.1.3Pessimistic Scenario94
TABLE 16PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY PATHOGEN, 2016–2020 (USD MILLION)94
TABLE 17PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY PATHOGEN, 2021–2026 (USD MILLION)95
7.1.2E. COLI95
7.1.2.1Proper food safety testing can limit the incidences of E. coli food poisoning95
FIGURE 37US: ANNUAL NUMBER OF E. COLI OUTBREAKS, 2009–201896
FIGURE 38TRANSMISSION CYCLE OF ETEC (ENTEROTOXIGENIC E. COLI)96
TABLE 18E. COLI TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT,
2016–2020 (USD MILLION)97
TABLE 19E. COLI TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT,
2021–2026 (USD MILLION)97
7.1.3SALMONELLA98
7.1.3.1Salmonella foodborne infection is found to be severe during summer than in winter98
FIGURE 39US: SALMONELLA OUTBREAKS, BY NUMBER AND CAUSE, 2009–201898
TABLE 20SALMONELLA TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT,
2016–2020 (USD MILLION)98
TABLE 21SALMONELLA TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT,
2021–2026 (USD MILLION)99
7.1.4CAMPYLOBACTER99
7.1.4.1WHO is strengthening disease surveillance to prevent foodborne illness99
FIGURE 40US: ANNUAL CAMPYLOBACTER OUTBREAKS, 2009–2018100
TABLE 22CAMPYLOBACTER TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT,
2016–2020 (USD MILLION)100
TABLE 23CAMPYLOBACTER TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT,
2021–2026 (USD MILLION)100
7.1.5LISTERIA101
7.1.5.1L. monocytogenes causes high hospitalization rate than any other foodborne pathogen101
TABLE 24LISTERIA TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT,
2016–2020 (USD MILLION)101
TABLE 25LISTERIA TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT,
2021–2026 (USD MILLION)101
7.1.6OTHER PATHOGENS102
TABLE 26OTHER PATHOGENS TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)102
TABLE 27OTHER PATHOGENS TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)102
8ENTERIC DISEASE TESTING MARKET, BY END USE103
8.1INTRODUCTION104
FIGURE 41EU: FREQUENCY DISTRIBUTION OF FOODBORNE OUTBREAKS THROUGH FOODS OF NON-ANIMAL ORIGIN, 2019104
FIGURE 42ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2021 VS. 2026 (USD MILLION)104
TABLE 28ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2016–2020 (USD MILLION)105
TABLE 29ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2021–2026 (USD MILLION)105
TABLE 30ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT,
2016–2020 (USD MILLION)105
TABLE 31ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT,
2021–2026 (USD MILLION)106
8.1.1COVID-19 IMPACT ON THE ENTERIC DISEASE TESTING MARKET, BY END USE106
8.1.1.1Realistic scenario106
TABLE 32REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY END USE, 2016–2020 (USD MILLION)106
TABLE 33REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY END USE, 2021–2026 (USD MILLION)107
8.1.1.2Optimistic scenario107
TABLE 34OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY END USE, 2016–2020 (USD MILLION)107
TABLE 35OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY END USE, 2021–2026 (USD MILLION)107
8.1.1.3Pessimistic scenario108
TABLE 36PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY END USE, 2016–2020 (USD MILLION)108
TABLE 37PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY END USE, 2021–2026 (USD MILLION)108
8.2FOOD108
8.2.1MEAT & POULTRY PRODUCTS TO PROVIDE MORE SCOPE FOR FOOD TESTING108
TABLE 38ENTERIC DISEASE TESTING MARKET FOR FOOD SOURCE, BY FOODBORNE PATHOGENS109
FIGURE 43EU: FOODBORNE DISEASE OUTBREAKS, 2017110
TABLE 39EU: OCCURRENCE OF CAMPYLOBACTER IN MAJOR FOOD CATEGORIES110
TABLE 40US: FOOD RECALLS, 2020111
TABLE 41ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY REGION,
2016–2020 (USD MILLION)112
TABLE 42ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY REGION,
2021–2026 (USD MILLION)113
TABLE 43ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY PATHOGEN,
2016–2020 (USD MILLION)113
TABLE 44ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY PATHOGEN,
2021–2026 (USD MILLION)113
8.2.2MEAT, POULTRY, AND SEAFOOD114
8.2.2.1Unclean slaughterhouses and processing plants are the key contributors to bacterial contamination114
FIGURE 44EU: FREQUENCY DISTRIBUTION OF FOODBORNE OUTBREAKS THROUGH FOODS OF ANIMAL ORIGIN, 2019114
TABLE 45ENTERIC DISEASE TESTING MARKET SIZE IN MEAT, POULTRY, AND SEAFOOD, BY REGION, 2016–2020 (USD MILLION)115
TABLE 46ENTERIC DISEASE TESTING MARKET SIZE IN MEAT, POULTRY, AND SEAFOOD, BY REGION, 2021–2026 (USD MILLION)115
TABLE 47ENTERIC DISEASE TESTING MARKET SIZE IN MEAT, POULTRY, & SEAFOOD,
BY PATHOGEN, 2016–2020 (USD MILLION)115
TABLE 48ENTERIC DISEASE TESTING MARKET SIZE IN MEAT, POULTRY, & SEAFOOD,
BY PATHOGEN, 2021–2026 (USD MILLION)116
8.2.3DAIRY PRODUCTS116
8.2.3.1Unhygienic storage conditions lead to contamination of dairy products116
FIGURE 45EU: FREQUENCY DISTRIBUTION OF ILLNESSES IN DAIRY PRODUCTS, 2019117
TABLE 49ENTERIC DISEASE TESTING MARKET SIZE IN DAIRY PRODUCTS, BY REGION, 2016–2020 (USD MILLION)117
TABLE 50ENTERIC DISEASE TESTING MARKET SIZE IN DAIRY PRODUCTS, BY REGION, 2021–2026 (USD MILLION)117
TABLE 51ENTERIC DISEASE TESTING MARKET SIZE IN DAIRY PRODUCTS,
BY PATHOGEN, 2016–2020 (USD MILLION)118
TABLE 52ENTERIC DISEASE TESTING MARKET SIZE IN DAIRY PRODUCTS,
BY PATHOGEN, 2021–2026 (USD MILLION)118
8.2.4PROCESSED FOOD118
8.2.4.1Ready-To-Eat foods are gaining more traction among consumers118
TABLE 53ENTERIC DISEASE TESTING MARKET SIZE IN PROCESSED FOOD, BY REGION, 2016–2020 (USD MILLION)119
TABLE 54ENTERIC DISEASE TESTING MARKET SIZE FOR PROCESSED FOOD,
BY REGION, 2021–2026 (USD MILLION)119
TABLE 55ENTERIC DISEASE TESTING MARKET IN PROCESSED FOODS, BY PATHOGEN, 2016–2020 (USD MILLION)120
TABLE 56ENTERIC DISEASE TESTING MARKET SIZE IN PROCESSED FOODS,
BY PATHOGEN, 2021–2026 (USD MILLION)120
8.2.5FRUITS & VEGETABLES120
8.2.5.1Good handling practices can help in the safe production of fresh produce120
TABLE 57ENTERIC DISEASE TESTING MARKET SIZE IN FRUITS & VEGETABLES,
BY REGION, 2016–2020 (USD MILLION)121
TABLE 58ENTERIC DISEASE TESTING MARKET SIZE IN FRUITS & VEGETABLES,
BY REGION, 2021–2026 (USD MILLION)121
TABLE 59ENTERIC DISEASE TESTING MARKET SIZE IN FRUITS & VEGETABLES,
BY PATHOGEN, 2016–2020 (USD MILLION)121
TABLE 60ENTERIC DISEASE TESTING MARKET SIZE IN FRUITS & VEGETABLES,
BY PATHOGEN, 2021–2026 (USD MILLION)122
8.2.6OTHER FOOD APPLICATIONS122
TABLE 61ENTERIC DISEASE TESTING MARKET SIZE IN OTHER FOOD APPLICATIONS,
BY REGION, 2016–2020 (USD MILLION)123
TABLE 62ENTERIC DISEASE TESTING MARKET SIZE IN OTHER FOOD APPLICATIONS,
BY REGION, 2021–2026 (USD MILLION)123
TABLE 63ENTERIC DISEASE TESTING MARKET SIZE IN OTHER FOOD APPLICATIONS,
BY PATHOGEN, 2016–2020 (USD MILLION)123
TABLE 64ENTERIC DISEASE TESTING MARKET SIZE IN OTHER FOOD APPLICATIONS,
BY PATHOGEN, 2021–2026 (USD MILLION)124
8.3WATER124
8.3.1POOR HYGIENIC CONDITIONS LEAD TO WATERBORNE DISEASES IN DEVELOPING REGIONS124
TABLE 65ENTERIC DISEASE TESTING MARKET SIZE IN WATER, BY REGION,
2016–2020 (USD MILLION)124
TABLE 66ENTERIC DISEASE TESTING MARKET SIZE IN WATER, BY REGION,
2021–2026 (USD MILLION)125
TABLE 67ENTERIC DISEASE TESTING MARKET SIZE IN WATER, BY PATHOGEN,
2016–2020 (USD MILLION)125
TABLE 68ENTERIC DISEASE TESTING MARKET SIZE IN WATER, BY PATHOGEN,
2021–2026 (USD MILLION)125
9ENTERIC DISEASE TESTING MARKET, BY TECHNOLOGY126
9.1INTRODUCTION127
FIGURE 46ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY,
2021 VS. 2026 (USD MILLION)127
TABLE 69ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY,
2016–2020 (USD MILLION)127
TABLE 70ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY,
2021–2026 (USD MILLION)128
9.1.1COVID-19 IMPACT ON THE ENTERIC DISEASE TESTING MARKET,
BY TECHNOLOGY128
9.1.1.1Realistic scenario128
TABLE 71REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY TECHNOLOGY, 2016–2020 (USD MILLION)128
TABLE 72REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY TECHNOLOGY, 2021–2026 (USD MILLION)128
9.1.1.2Optimistic scenario129
TABLE 73OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY TECHNOLOGY, 2016–2020 (USD MILLION)129
TABLE 74OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY TECHNOLOGY, 2021–2026 (USD MILLION)129
9.1.1.3Pessimistic scenario129
TABLE 75PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY TECHNOLOGY, 2016–2020 (USD MILLION)129
TABLE 76PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY TECHNOLOGY, 2021–2026 (USD MILLION)129
9.2TRADITIONAL130
9.2.1CULTURAL TECHNIQUES HAVE BEEN PREFERRED FOR BOTH READY-TO-EAT FOODS AND FRESH PRODUCE130
TABLE 77TRADITIONAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION,
2016–2020 (USD MILLION)130
TABLE 78TRADITIONAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION,
2021–2026 (USD MILLION)131
9.3RAPID131
TABLE 79ENTERIC DISEASE TESTING MARKET SIZE FOR RAPID TECHNOLOGY,
BY REGION, 2016–2020 (USD MILLION)132
TABLE 80RAPID ENTERIC DISEASE TESTING MARKET SIZE, BY REGION,
2021–2026 (USD MILLION)132
TABLE 81RAPID ENTERIC DISEASE TESTING MARKET SIZE, BY SUBSEGMENT,
2016–2020 (USD MILLION)132
TABLE 82RAPID ENTERIC DISEASE TESTING MARKET SIZE, BY SUBSEGMENT,
2021–2026 (USD MILLION)133
9.3.1CONVENIENCE-BASED133
9.3.1.1Helps detect microorganisms based on their biochemical reactions under standard growth conditions133
9.3.2POLYMERASE CHAIN REACTION (PCR)133
9.3.2.1Real-time PCR involves fluorescent ethidium bromide monoazide dye that prevent the detection of dead organisms133
9.3.3IMMUNOASSAY134
9.3.3.1ELISA is based on the protein’s characteristic of binding to specific enzyme-labeled antibodies134
9.3.4CHROMATOGRAPHY & SPECTROMETRY135
9.3.4.1Inductively Coupled Plasma (ICP) is one of the major advancements of mass spectrometry135
10ENTERIC DISEASE TESTING MARKET, BY REGION136
10.1INTRODUCTION137
FIGURE 47REGION-WISE FOOD SAFETY EVENTS, 2020137
FIGURE 48US ESTIMATED TO GROW AT THE HIGHEST GROWTH RATE IN THE ENTERIC DISEASE TESTING MARKET, 2021–2026138
TABLE 83ENTERIC DISEASE TESTING MARKET SIZE, BY REGION,
2016–2020 (USD MILLION)138
TABLE 84ENTERIC DISEASE TESTING MARKET SIZE, BY REGION,
2021–2026 (USD MILLION)139
10.1.1COVID-19 IMPACT ON THE ENTERIC DISEASE TESTING MARKET, BY REGION139
10.1.1.1Realistic scenario139
TABLE 85REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2016–2020 (USD MILLION)139
TABLE 86REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2021–2026 (USD MILLION)140
10.1.1.2Optimistic scenario140
TABLE 87OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY REGION, 2016–2020 (USD MILLION)140
TABLE 88OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY REGION, 2021–2026 (USD MILLION)140
10.1.1.3Pessimistic scenario141
TABLE 89PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY REGION, 2016–2020 (USD MILLION)141
TABLE 90PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY REGION, 2021–2026 (USD MILLION)141
10.2NORTH AMERICA141
FIGURE 49NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SNAPSHOT, 2020142
TABLE 91NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2016–2020 (USD MILLION)143
TABLE 92NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2021–2026 (USD MILLION)143
TABLE 93NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)143
TABLE 94NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)144
TABLE 95NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2016–2020 (USD MILLION)144
TABLE 96NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2021–2026 (USD MILLION)144
10.2.1US145
10.2.1.1FSIS is the regulating body that enforces food safety regulations145
FIGURE 50NUMBER OF DEATHS RELATED TO CONFIRMED INFECTIONS, BY PATHOGEN, 2010–2018145
FIGURE 51US: FOODBORNE PATHOGEN INCIDENCE RATE PER 100,000 PERSONS, 2010–2016146
TABLE 97US: ESTIMATED EFFECTS OF FOODBORNE AGENTS (2016)146
FIGURE 52US: INCIDENCES RELATED TO THE TOP FIVE FOODBORNE PATHOGENS, 2016147
TABLE 98US: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2016–2020 (USD MILLION)147
TABLE 99US: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2021–2026 (USD MILLION)148
TABLE 100US: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)148
TABLE 101US: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)148
10.2.2CANADA149
10.2.2.1Canadian government imposed stringent regulations on exports to ensure food safety149
TABLE 102CANADA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2016–2020 (USD MILLION)149
TABLE 103CANADA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2021–2026 (USD MILLION)149
TABLE 104CANADA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2016–2020 (USD MILLION)150
TABLE 105CANADA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2021–2026 (USD MILLION)150
10.2.3MEXICO151
10.2.3.1Rise in the number of foodborne disease cases has increased focus on food safety in the country151
TABLE 106MEXICO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2016–2020 (USD MILLION)151
TABLE 107MEXICO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2021–2026 (USD MILLION)151
TABLE 108MEXICO: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2016–2020 (USD MILLION)152
TABLE 109MEXICO: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2021–2026 (USD MILLION)152
10.3EUROPE152
FIGURE 53EU/EEA: DISTRIBUTION OF CONFIRMED CAMPYLOBACTERIOSIS CASES
AND RATES PER 100 000 POPULATION BY YEAR AND COUNTRY, 2013–2017153
FIGURE 54EUROPE: ENTERIC DISEASE TESTING MARKET SNAPSHOT, 2020154
TABLE 110EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY,
2016–2020 (USD MILLION)155
TABLE 111EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY,
2021–2026 (USD MILLION)155
TABLE 112EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2016–2020 (USD MILLION)156
TABLE 113EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2021–2026 (USD MILLION)156
TABLE 114EUROPE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2016–2020 (USD MILLION)156
TABLE 115EUROPE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2021–2026 (USD MILLION)157
10.3.1GERMANY157
10.3.1.1International food trade has increased food safety risks157
FIGURE 55GERMANY: ACTIVE FOOD TESTING CARRIED OUT FOR VARIOUS FOOD PATHOGENS IN MULTIPLE FOOD PRODUCTS, 2019158
TABLE 116GERMANY: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2016–2020 (USD MILLION)158
TABLE 117GERMANY: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2021–2026 (USD MILLION)159
TABLE 118GERMANY: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2016–2020 (USD MILLION)159
TABLE 119GERMANY: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2021–2026 (USD MILLION)159
10.3.2FRANCE160
10.3.2.1Large number of foodborne outbreaks in meat-based food encouraging the growth of enteric disease testing160
TABLE 120FRANCE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2016–2020 (USD MILLION)160
TABLE 121FRANCE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2021–2026 (USD MILLION)160
TABLE 122FRANCE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2016–2020 (USD MILLION)161
TABLE 123FRANCE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2021–2026 (USD MILLION)161
10.3.3SPAIN161
10.3.3.1Outbreak of listeriosis will have serious implications on the Spanish meat industry161
TABLE 124SPAIN: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2016–2020 (USD MILLION)162
TABLE 125SPAIN: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2021–2026 (USD MILLION)162
TABLE 126SPAIN: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)162
TABLE 127SPAIN: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)163
10.3.4ITALY163
10.3.4.1Products of animal origin products are found to be more problematic in this region163
TABLE 128ITALY: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2016–2020 (USD MILLION)163
TABLE 129ITALY: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2021–2026 (USD MILLION)164
TABLE 130ITALY: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)164
TABLE 131ITALY: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)164
10.3.5POLAND165
10.3.5.1Increase in incidences of Salmonella outbreaks drives awareness about food safety165
TABLE 132POLAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2016–2020 (USD MILLION)165
TABLE 133POLAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2021–2026 (USD MILLION)165
TABLE 134POLAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENTS, 2016–2020 (USD MILLION)166
TABLE 135POLAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2021–2026 (USD MILLION)166
10.3.6UK167
10.3.6.1Norovirus infection is estimated to occur every year in the UK167
TABLE 136UK: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2016–2020 (USD MILLION)167
TABLE 137UK: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2021–2026 (USD MILLION)167
TABLE 138UK: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)167
TABLE 139UK: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)168
10.3.7REST OF EUROPE168
TABLE 140REST OF EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)168
TABLE 141REST OF EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)169
TABLE 142REST OF EUROPE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2016–2020 (USD MILLION)169
TABLE 143REST OF EUROPE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2021–2026 (USD MILLION)169
10.4ASIA PACIFIC170
TABLE 144ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE,
BY COUNTRY/REGION, 2016–2020 (USD MILLION)170
TABLE 145ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE,
BY COUNTRY/REGION, 2021–2026 (USD MILLION)170
TABLE 146ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2016–2020 (USD MILLION)171
TABLE 147ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2021–2026 (USD MILLION)171
TABLE 148ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2016–2020 (USD MILLION)171
TABLE 149ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2021–2026 (USD MILLION)172
10.4.1JAPAN172
10.4.1.1E. coli to be the major pathogen found to affect people172
TABLE 150JAPAN: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2016–2020 (USD MILLION)172
TABLE 151JAPAN: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2021–2026 (USD MILLION)173
TABLE 152JAPAN: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)173
TABLE 153JAPAN: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)173
10.4.2CHINA174
10.4.2.1Microbial contamination is reported to be the biggest food safety risk174
TABLE 154CHINA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2016–2020 (USD MILLION)174
TABLE 155CHINA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2021–2026 (USD MILLION)174
TABLE 156CHINA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)175
TABLE 157CHINA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)175
10.4.3INDIA175
10.4.3.1FSSAI to safeguard the quality of food produced175
TABLE 158INDIA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2016–2020 (USD MILLION)176
TABLE 159INDIA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2021–2026 (USD MILLION)176
TABLE 160INDIA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)176
TABLE 161INDIA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)177
10.4.4AUSTRALIA & NEW ZEALAND177
10.4.4.1Gastroenteritis occurs every year, affecting several people177
TABLE 162AUSTRALIA & NEW ZEALAND: ENTERIC DISEASE TESTING MARKET SIZE,
BY END USE, 2016–2020 (USD MILLION)177
TABLE 163AUSTRALIA & NEW ZEALAND: ENTERIC DISEASE TESTING MARKET SIZE,
BY END USE, 2021–2026 (USD MILLION)178
TABLE 164AUSTRALIA & NEW ZEALAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)178
TABLE 165AUSTRALIA & NEW ZEALAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)178
10.4.5THAILAND179
10.4.5.1Demand for food exports to boost the growth of the market179
TABLE 166THAILAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2016–2020 (USD MILLION)179
TABLE 167THAILAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2021–2026 (USD MILLION)179
TABLE 168THAILAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2016–2020 (USD MILLION)180
TABLE 169THAILAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2021–2026 (USD MILLION)180
10.4.6REST OF ASIA PACIFIC180
TABLE 170REST OF ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE,
BY END USE, 2016–2020 (USD MILLION)181
TABLE 171REST OF ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE,
BY END USE, 2021–2026 (USD MILLION)181
TABLE 172REST OF ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2016–2020 (USD MILLION)181
TABLE 173REST OF ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2021–2026 (USD MILLION)182
10.5SOUTH AMERICA182
TABLE 174SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2016–2020 (USD MILLION)182
TABLE 175SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2021–2026 (USD MILLION)183
TABLE 176SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)183
TABLE 177SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)183
TABLE 178SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET FOR FOOD END USE, BY SUBSEGMENT,2016–2020 (USD MILLION)184
TABLE 179SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2021–2026 (USD MILLION)184
10.5.1BRAZIL184
10.5.1.1Export of agricultural produce to boost the demand for enteric disease testing184
TABLE 180BRAZIL: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2016–2020 (USD MILLION)185
TABLE 181BRAZIL: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2021–2026 (USD MILLION)185
TABLE 182BRAZIL: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2016–2020 (USD MILLION)185
TABLE 183BRAZIL: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2021–2026 (USD MILLION)186
10.5.2ARGENTINA186
10.5.2.1Food companies are taking preventive measures for pathogen infections186
TABLE 184ARGENTINA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2016–2020 (USD MILLION)186
TABLE 185ARGENTINA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2021–2026 (USD MILLION)187
TABLE 186ARGENTINA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2016–2020 (USD MILLION)187
TABLE 187ARGENTINA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2021–2026 (USD MILLION)187
10.5.3REST OF SOUTH AMERICA188
TABLE 188REST OF SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE,
BY END USE, 2016–2020 (USD MILLION)188
TABLE 189REST OF SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE,
BY END USE, 2021–2026 (USD MILLION)188
TABLE 190REST OF SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)188
TABLE 191REST OF SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)189
10.6REST OF THE WORLD (ROW)189
TABLE 192ROW: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY/REGION, 2016–2020 (USD MILLION)189
TABLE 193ROW: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY/REGION, 2021–2026 (USD MILLION)190
TABLE 194ROW: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2016–2020 (USD MILLION)190
TABLE 195ROW: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2021–2026 (USD MILLION)190
TABLE 196ROW: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)190
TABLE 197ROW: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)191
10.6.1SOUTH AFRICA191
10.6.1.1Growth in the demand to follow international standards is encouraging enteric disease testing191
TABLE 198SOUTH AFRICA: ENTERIC DISEASE TESTING MARKET SIZE,
BY END USE, 2016–2020 (USD MILLION)191
TABLE 199SOUTH AFRICA: ENTERIC DISEASE TESTING MARKET SIZE,
BY END USE, 2021–2026 (USD MILLION)192
TABLE 200SOUTH AFRICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2016–2020 (USD MILLION)192
TABLE 201SOUTH AFRICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2021–2026 (USD MILLION)192
10.6.2MIDDLE EAST193
10.6.2.1Food safety services are driven by food imports from other countries193
TABLE 202MIDDLEAST: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2016–2020 (USD MILLION)193
TABLE 203MIDDLEAST: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2021–2026 (USD MILLION)193
TABLE 204MIDDLEAST: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2016–2020 (USD MILLION)194
TABLE 205MIDDLEAST: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2021–2026 (USD MILLION)194
11COMPETITIVE LANDSCAPE195
11.1OVERVIEW195
11.2OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN THE ENTERIC DISEASES TESTING MARKET196
11.3MARKET SHARE ANALYSIS, 2020197
FIGURE 56MARKET SHARE OBTAINED BY DOMINANT AND OTHER PLAYERS197
11.4COVID-19-SPECIFIC COMPANY RESPONSE198
11.4.1SGS SA198
11.4.2MERCK KGAA198
11.4.3EUROFINS SCIENTIFIC198
11.5COMPANY EVALUATION QUADRANT (KEY PLAYERS)198
11.5.1STARS199
11.5.2EMERGING LEADERS199
11.5.3PERVASIVE PLAYERS199
11.5.4PARTICIPANTS199
FIGURE 57ENTERIC DISEASE TESTING MARKET: COMPANY EVALUATION QUADRANT, 2020 (KEY PLAYERS)200
11.6PRODUCT FOOTPRINT201
TABLE 206COMPANY FOOTPRINT, BY TECHNOLOGY201
TABLE 207COMPANY FOOTPRINT, BY END-USE202
TABLE 208COMPANY FOOTPRINT, BY REGION203
11.7COMPANY EVALUATION QUADRANT (START-UP/SME)204
11.7.1PROGRESSIVE COMPANIES204
11.7.2STARTING BLOCKS204
11.7.3RESPONSIVE COMPANIES204
11.7.4DYNAMIC COMPANIES204
FIGURE 58ENTERIC DISEASE TESTING MARKET: COMPANY EVALUATION QUADRANT, 2020 (START-UPS/SME)205
11.8COMPETITIVE SCENARIO205
11.8.1NEW PRODUCTS LAUNCHES205
TABLE 209ENTERIC DISEASE TESTING MARKET: NEW PRODUCT LAUNCHES, JULY 2019205
11.8.2DEALS206
TABLE 210ENTERIC DISEASE TESTING MARKET: DEALS, MAY 2017- JULY 2021206
11.8.3OTHER DEVELOPMENTS207
TABLE 211ENTERIC DISEASE TESTING MARKET: OTHER DEVELOPMENTS,
MAY 2018- JUNE 2021207
12COMPANY PROFILES208
(Business overview, Products offered, Recent developments & MnM View)*
12.1KEY COMPANIES208
12.1.1SGS SA208
TABLE 212SGS SA: BUSINESS OVERVIEW208
FIGURE 59SGS SA: COMPANY SNAPSHOT209
TABLE 213SGS SA: PRODUCT OFFERINGS209
TABLE 214SGA SA: DEALS210
TABLE 215SGS SA: OTHERS210
12.1.2MERCK KGAA212
TABLE 216MERCK KGAA: BUSINESS OVERVIEW212
FIGURE 60MERCK KGAA: COMPANY SNAPSHOT213
TABLE 217MERCK KGAA: PRODUCT OFFERINGS213
12.1.3THERMO FISHER SCIENTIFIC INC.215
TABLE 218THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW215
FIGURE 61THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT216
TABLE 219THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS216
TABLE 220THERMO FISHER SCIENTIFIC INC.: DEALS218
12.1.4EUROFINS SCIENTIFIC219
TABLE 221EUROFINS SCIENTIFIC: BUSINESS OVERVIEW219
FIGURE 62EUROFINS SCIENTIFIC: COMPANY SNAPSHOT220
TABLE 222EUROFINS SCIENTIFIC: PRODUCT OFFERINGS220
TABLE 223EUROFINS SCIENTIFIC: DEALS221
TABLE 224EUROFINS SCIENTIFIC: OTHER DEVELOPMENTS222
12.1.5ALS LIMITED223
TABLE 225ALS LIMITED: BUSINESS OVERVIEW223
FIGURE 63ALS LIMITED: COMPANY SNAPSHOT223
TABLE 226ALS LIMITED: PRODUCT OFFERINGS224
TABLE 227ALS LIMITED: DEALS224
TABLE 228ALS LIMITED: OTHER DEVELOPMENTS225
12.1.6ASURE QUALITY226
TABLE 229ASURE QUALITY: BUSINESS OVERVIEW226
FIGURE 64ASURE QUALITY: COMPANY SNAPSHOT226
TABLE 230ASURE QUALITY: PRODUCT OFFERINGS227
12.1.7BUREAU VERITAS228
TABLE 231BUREAU VERITAS: BUSINESS OVERVIEW228
FIGURE 65BUREAU VERITAS: COMPANY SNAPSHOT229
TABLE 232BUREAU VERITAS: PRODUCT OFFERINGS229
12.1.8INTERTEK231
TABLE 233INTERTEK: BUSINESS OVERVIEW231
FIGURE 66INTERTEK: COMPANY SNAPSHOT232
TABLE 234INTERTEK: PRODUCT OFFERINGS232
TABLE 235INTERTEK: DEALS233
12.1.9BIO-RAD LABORATORIES, INC.234
TABLE 236BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW234
FIGURE 67BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT234
TABLE 237BIO-RAD LABORATORIES, INC.: PRODUCT OFFERINGS235
12.1.10BECTON DICKINSON237
TABLE 238BECTON DICKINSON: BUSINESS OVERVIEW237
FIGURE 68BECTON DICKINSON: COMPANY SNAPSHOT238
TABLE 239BECTON DICKINSON: PRODUCT OFFERINGS238
12.1.113M240
TABLE 2403M: BUSINESS OVERVIEW240
FIGURE 693M: COMPANY SNAPSHOT240
TABLE 2413M: PRODUCT OFFERINGS241
12.1.12PERKINELMER, INC.242
TABLE 242PERKINELMER, INC.: BUSINESS OVERVIEW242
FIGURE 70PERKINELMER, INC.: COMPANY SNAPSHOT243
TABLE 243PERKINELMER, INC.: PRODUCT OFFERINGS244
12.1.13NEOGEN CORPORATION245
TABLE 244NEOGEN CORPORATION: BUSINESS OVERVIEW245
FIGURE 71NEOGEN CORPORATION: COMPANY SNAPSHOT245
TABLE 245NEOGEN CORPORATION: PRODUCT OFFERINGS246
12.1.14MÉRIEUX NUTRISCIENCES248
TABLE 246MÉRIEUX NUTRISCIENCES: BUSINESS OVERVIEW248
TABLE 247MÉRIEUX NUTRISCIENCES: PRODUCT OFFERINGS248
TABLE 248MÉRIEUX NUTRISCIENCES: DEALS249
12.1.15TÜV SÜD250
TABLE 249TÜV SÜD: BUSINESS OVERVIEW250
TABLE 250TÜV SÜD: PRODUCT OFFERINGS250
*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.
 
12.2OTHER PLAYERS251
12.2.1HARDY DIAGNOSTICS251
TABLE 251HARDY DIAGNOSTICS: BUSINESS OVERVIEW251
TABLE 252HARDY DIAGNOSTICS: PRODUCT OFFERINGS251
TABLE 253HARDY DIAGNOSTICS: NEW PRODUCT LAUNCH252
12.2.2ROMER LABS253
TABLE 254ROMER LABS: BUSINESS OVERVIEW253
TABLE 255ROMER LABS: PRODUCT OFFERINGS253
12.2.3NOVA BIOLOGICALS254
TABLE 256NOVA BIOLOGICALS: BUSINESS OVERVIEW254
TABLE 257NOVA BIOLOGICALS: PRODUCT OFFERINGS254
12.2.4SYMBIO LABORATORIES255
TABLE 258SYMBIO LABORATORIES: BUSINESS OVERVIEW255
TABLE 259SYMBIO LABORATORIES: PRODUCT OFFERINGS255
12.2.5CERTIFIED LABORATORIES256
13ADJACENT AND RELATED MARKETS257
13.1INTRODUCTION257
TABLE 260ADJACENT MARKETS TO ENTERIC DISEASE TESTING MARKET257
13.2LIMITATIONS257
13.3FOOD PATHOGEN TESTING MARKET257
13.3.1MARKET DEFINITION257
13.3.2MARKET OVERVIEW258
TABLE 261E. COLI MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)259
TABLE 262SALMONELLA MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)259
TABLE 263CAMPYLOBACTER MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)259
TABLE 264LISTERIA MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)260
13.4FOOD TESTING KITS MARKET260
13.4.1MARKET DEFINITION260
13.4.2MARKET OVERVIEW260
TABLE 265FOOD TESTING KITS MARKET SIZE IN MEAT, POULTRY,
AND SEAFOOD PRODUCTS, BY REGION, 2015–2022 (USD MILLION)261
TABLE 266FOOD TESTING KITS MARKET SIZE IN DAIRY PRODUCTS, BY REGION,
2015–2022 (USD MILLION)261
TABLE 267FOOD TESTING KITS MARKET SIZE IN PROCESSED FOOD, BY REGION,
2015–2022 (USD MILLION)261
TABLE 268FOOD TESTING KITS MARKET SIZE IN FRUITS & VEGETABLES, BY REGION, 2015–2022 (USD MILLION)262
 
13.5MICROBIAL WATER TESTING MARKET262
13.5.1MARKET DEFINITION262
13.5.2MARKET OVERVIEW263
TABLE 269MICROBIAL WATER TESTING SOLUTIONS MARKET SIZE, BY WATER TYPE, 2015–2022 (USD MILLION)263
TABLE 270MICROBIAL WATER TESTING SOLUTIONS MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION)263
TABLE 271DRINKING & BOTTLED MICROBIAL WATER TESTING SOLUTIONS MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)264
TABLE 272INDUSTRIAL MICROBIAL WATER TESTING SOLUTIONS MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)264
14APPENDIX265
14.1DISCUSSION GUIDE265
14.2KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL269
14.3AVAILABLE CUSTOMIZATIONS271
14.4RELATED REPORTS272
14.5AUTHOR DETAILS273

お問合せフォーム